Dihydromyricetin

Dihydromyricetin

What the trials found

Dihydromyricetin does not appear to reliably relieve alcohol-related fatigue or headache in humans, because available evidence is limited to a single early study rather than convincing clinical proof.

  • 1 papers
  • 0 of 2 outcomes

Risk, worst reported severity

  • elevation of alanine aminotransferase (ALT)
  • elevation of aspartate aminotransferase (AST)
  • adriamycin moderate
  • acetaminophen moderate
All 11 events and interactions
Protocol

Dose, timing & forms

How much

There is not enough human trial evidence to give a dependable dose range for fatigue or headache. One early paper is not a foundation for a consumer dosing rule, especially when the available mechanistic work comes from animal research rather than outcome-focused human trials.1

When and how long

No evidence-based before-drinking, after-drinking, or next-morning schedule has been established for DHM. Avoid treating timing as a workaround for alcohol impairment: neither alertness nor driving safety follows from the early receptor research.1

Forms & standardisation

Look for a product that clearly states the amount of dihydromyricetin per serving and identifies the botanical source, such as vine tea or Hovenia dulcis. Standardized DHM products have more relevance than vague proprietary blends, but standardization does not turn the limited human evidence into proof of benefit.1

Adverse events and drug interactions

Safety events

elevation of alanine aminotransferase (ALT)
elevation of aspartate aminotransferase (AST)
elevation of blood urea nitrogen (BUN)
increased creatinine
increased mean corpuscular hemoglobin concentration (MCHC)
no observed adverse effect (NOAEL > 1998 mg/kg/day)

Drug interactions

adriamycin moderate additive
acetaminophen moderate decreases effect
methotrexate moderate decreases effect
acetaminophen minor decreases effect
fluconazole minor unknown
In context

What this is and how it works

  • One human paper evaluated dihydromyricetin for alcohol-related effects without establishing reliable reductions in fatigue or headache.1
  • The evidence reviewed here spans one paper and two outcomes, limiting conclusions across alcohol-related fatigue and headache.
  • Medication interactions and liver or kidney safety concerns warrant caution when considering dihydromyricetin.1

Dihydromyricetin, often shortened to DHM, is a flavonoid found in vine tea and Hovenia dulcis, also called the Japanese raisin tree. It has a long history of interest in East Asian herbal traditions, while modern supplements usually isolate and concentrate the compound.1

In animal research, DHM interacts with GABA-A receptors, the brain's brake-pedal signaling system that alcohol pushes hard.1 Think of it as adjusting a brake that alcohol has pressed too far, rather than sweeping alcohol out of your body. That receptor finding does not establish that DHM reliably eases fatigue or headache in people.1

Bottom line

DHM is a reasonable topic to watch if you are curious about alcohol-related fatigue or headache, but it is not a proven solution for either. Skip it if you want a reliably evidence-based hangover strategy, and take the listed liver and kidney related safety signals and medication interactions seriously.

Frequently asked

Common questions

Does dihydromyricetin help with hangovers?

The idea comes from early research into alcohol-related symptoms, including fatigue and headache, but the human evidence is far too limited to call it a proven hangover supplement.1

What is dihydromyricetin made from?

Dihydromyricetin is a plant flavonoid, a natural compound found in vine tea and in the Japanese raisin tree, Hovenia dulcis. Supplements usually provide an isolated extract rather than tea.1

Can you take dihydromyricetin before drinking alcohol?

There is no established timing protocol that reliably prevents alcohol-related symptoms. Do not treat it as a safety net for drinking, since it does not remove alcohol from your bloodstream or make driving safe.1

Sources

Sources

  1. 1. Dihydromyricetin as a novel anti-alcohol intoxication medication (2012)

Generated August 27, 2026